BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.120
+0.010 (0.32%)
At close: May 12, 2025, 4:00 PM
3.150
+0.030 (0.96%)
After-hours: May 12, 2025, 7:56 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $17.76 million as of May 12, 2025. Its market cap has decreased by -49.27% in one year.
Market Cap
17.76M
Enterprise Value
12.18M
1-Year Change
-49.27%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $17.76M, a decrease of -31.71%. That is a compound annual growth rate of -8.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 11.50M | -54.00% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |